메뉴 건너뛰기




Volumn 87, Issue 5, 2013, Pages 932-938

Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMAL RADIATION THERAPY; DOSE-VOLUME HISTOGRAMS; INTENSITY MODULATED RADIATION THERAPY; LATE RECTAL TOXICITIES; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; PLANNING TARGET VOLUMES; RADIATION THERAPY ONCOLOGY GROUPS;

EID: 84888299318     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.07.041     Document Type: Article
Times cited : (249)

References (28)
  • 1
    • 40949147326 scopus 로고    scopus 로고
    • Quality of life and satisfaction with outcome among prostate-cancer survivors
    • M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
    • (2008) N Engl J Med , vol.358 , pp. 1250-1261
    • Sanda, M.G.1    Dunn, R.L.2    Michalski, J.3
  • 2
    • 33847634256 scopus 로고    scopus 로고
    • Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields
    • A.B. Jani, A. Su, and D. Correa Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields Prostate Cancer Prostatic Dis 10 2007 82 86
    • (2007) Prostate Cancer Prostatic Dis , vol.10 , pp. 82-86
    • Jani, A.B.1    Su, A.2    Correa, D.3
  • 3
    • 33748096108 scopus 로고    scopus 로고
    • Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer
    • M.J. Zelefsky, H. Chan, and M. Hunt Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer J Urol 127 2006 1415 1419
    • (2006) J Urol , vol.127 , pp. 1415-1419
    • Zelefsky, M.J.1    Chan, H.2    Hunt, M.3
  • 4
    • 33748143474 scopus 로고    scopus 로고
    • Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
    • G. Sanguineti, M.L. Cavey, and E.J. Endres Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy? Strahlenther Onkol 182 2006 543 549
    • (2006) Strahlenther Onkol , vol.182 , pp. 543-549
    • Sanguineti, G.1    Cavey, M.L.2    Endres, E.J.3
  • 5
    • 0035156326 scopus 로고    scopus 로고
    • Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer
    • H.K. Shu, T.T. Lee, and E. Vigneauly Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer Urology 57 2001 102 107
    • (2001) Urology , vol.57 , pp. 102-107
    • Shu, H.K.1    Lee, T.T.2    Vigneauly, E.3
  • 6
    • 34447265271 scopus 로고    scopus 로고
    • Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer
    • S.A. Vora, W.W. Wong, and S.E. Schild Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 68 2007 1053 1058
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , pp. 1053-1058
    • Vora, S.A.1    Wong, W.W.2    Schild, S.E.3
  • 8
    • 0000120995 scopus 로고
    • A class of K-sample tests for comparing the cumulative incidence of a competing risk
    • R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1143
    • (1988) Ann Stat , vol.16 , pp. 1141-1143
    • Gray, R.J.1
  • 9
    • 1542532754 scopus 로고    scopus 로고
    • A proportional hazards model for the sub distribution of a competing risk
    • G.R. Fine A proportional hazards model for the sub distribution of a competing risk J Am Stat Assoc 94 1999 496 509
    • (1999) J Am Stat Assoc , vol.94 , pp. 496-509
    • Fine, G.R.1
  • 10
    • 0036837324 scopus 로고    scopus 로고
    • Treatment of prostate cancer with radiotherapy: Should the entire seminal vesicles be included in the clinical target volume?
    • L. Kestin, N. Goldstein, and F. Vicini Treatment of prostate cancer with radiotherapy: Should the entire seminal vesicles be included in the clinical target volume? Int J Radiat Oncol Biol Phys 54 2002 686 697
    • (2002) Int J Radiat Oncol Biol Phys , vol.54 , pp. 686-697
    • Kestin, L.1    Goldstein, N.2    Vicini, F.3
  • 11
    • 84861615341 scopus 로고    scopus 로고
    • Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas
    • H.A. Gay, H.J. Barthold, and E. O'Meara Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas Int J Radiat Oncol Biol Phys 83 2013 3353 3362
    • (2013) Int J Radiat Oncol Biol Phys , vol.83 , pp. 3353-3362
    • Gay, H.A.1    Barthold, H.J.2    O'Meara, E.3
  • 12
    • 0033959048 scopus 로고    scopus 로고
    • Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406
    • J.M. Michalski, J.A. Purdy, and K. Winter Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 Int J Radiat Oncol Biol Phys 46 2000 391 402
    • (2000) Int J Radiat Oncol Biol Phys , vol.46 , pp. 391-402
    • Michalski, J.M.1    Purdy, J.A.2    Winter, K.3
  • 13
    • 2142704474 scopus 로고    scopus 로고
    • Preliminary report of toxicity following 3D conformal radiation therapy (3DCRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy)
    • J.K. Ryu, K. Winter, and J.M. Michalski Preliminary report of toxicity following 3D conformal radiation therapy (3DCRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy) Int J Radiat Oncol Biol Phys 51 2001 136 137
    • (2001) Int J Radiat Oncol Biol Phys , vol.51 , pp. 136-137
    • Ryu, J.K.1    Winter, K.2    Michalski, J.M.3
  • 14
    • 10044274200 scopus 로고    scopus 로고
    • Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study
    • M. Roach, K. Winter, and J.M. Michalski Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study Int J Radiat Oncol Biol Phys 60 2004 1351 1356
    • (2004) Int J Radiat Oncol Biol Phys , vol.60 , pp. 1351-1356
    • Roach, M.1    Winter, K.2    Michalski, J.M.3
  • 15
    • 67049172698 scopus 로고    scopus 로고
    • ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer. Expert panel on radiation oncology-prostate
    • J.M. Michalski, M. Roach III, and G. Merrick ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer. Expert panel on radiation oncology-prostate Int J Radiat Oncol Biol Phys 74 2009 667 672
    • (2009) Int J Radiat Oncol Biol Phys , vol.74 , pp. 667-672
    • Michalski, J.M.1    Roach III, M.2    Merrick, G.3
  • 16
    • 0033153217 scopus 로고    scopus 로고
    • Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma
    • M.J. Zelefsky, D. Cowen, and Z. Fuks Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 1999 2460 2468
    • (1999) Cancer , vol.85 , pp. 2460-2468
    • Zelefsky, M.J.1    Cowen, D.2    Fuks, Z.3
  • 17
    • 54049148613 scopus 로고    scopus 로고
    • Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer
    • A. Al-Mamgani, W.L. van Putten, and W.D. Heemsbergen Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 72 2008 980 988
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 980-988
    • Al-Mamgani, A.1    Van Putten, W.L.2    Heemsbergen, W.D.3
  • 18
    • 34249316816 scopus 로고    scopus 로고
    • Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial
    • D.P. Dearnaley, M.R. Sydes, and J.D. Graham Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial Lancet Oncol 8 2007 475 487
    • (2007) Lancet Oncol , vol.8 , pp. 475-487
    • Dearnaley, D.P.1    Sydes, M.R.2    Graham, J.D.3
  • 19
    • 37049023209 scopus 로고    scopus 로고
    • Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
    • D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , pp. 67-74
    • Kuban, D.A.1    Tucker, S.L.2    Dong, L.3
  • 20
    • 24644443217 scopus 로고    scopus 로고
    • Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial
    • A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239
    • (2005) JAMA , vol.294 , pp. 1233-1239
    • Zietman, A.L.1    Desilvio, M.L.2    Slater, J.D.3
  • 21
    • 33644516600 scopus 로고    scopus 로고
    • Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer
    • S.T. Peeters, J.V. Lebesque, and W.D. Heemsbergen Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 64 2006 1151 1161
    • (2006) Int J Radiat Oncol Biol Phys , vol.64 , pp. 1151-1161
    • Peeters, S.T.1    Lebesque, J.V.2    Heemsbergen, W.D.3
  • 22
    • 0036680314 scopus 로고    scopus 로고
    • Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial
    • A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
    • (2002) Int J Radiat Oncol Biol Phys , vol.53 , pp. 1097-1105
    • Pollack, A.1    Zagars, G.K.2    Starkschall, G.3
  • 23
    • 22144477117 scopus 로고    scopus 로고
    • Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy
    • C. Vargas, A. Martinez, and L.L. Kestin Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy Int J Radiat Oncol Biol Phys 62 2005 1297 1308
    • (2005) Int J Radiat Oncol Biol Phys , vol.62 , pp. 1297-1308
    • Vargas, C.1    Martinez, A.2    Kestin, L.L.3
  • 24
    • 39749192109 scopus 로고    scopus 로고
    • Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer
    • M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , pp. 1124-1129
    • Zelefsky, M.J.1    Levin, E.J.2    Hunt, M.3
  • 25
    • 0036804604 scopus 로고    scopus 로고
    • Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: Longer term follow-up of a phase III trial - Trans-Tasman Radiation Oncology Group
    • P.C. O'Brien, C.I. Franklin, and M.G. Poulsen Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial - Trans-Tasman Radiation Oncology Group Int J Radiat Oncol Biol Phys 54 2002 442 449
    • (2002) Int J Radiat Oncol Biol Phys , vol.54 , pp. 442-449
    • O'Brien, P.C.1    Franklin, C.I.2    Poulsen, M.G.3
  • 26
    • 80155157732 scopus 로고    scopus 로고
    • Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer
    • J.E. Bekelman, N. Mitra, and J. Efstathiou Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer Int J Radiat Oncol Biol Phys 81 2011 e325 e334
    • (2011) Int J Radiat Oncol Biol Phys , vol.81
    • Bekelman, J.E.1    Mitra, N.2    Efstathiou, J.3
  • 27
    • 84859846433 scopus 로고    scopus 로고
    • Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer
    • N.C. Sheets, G.H. Goldin, and A.M. Meyer Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer JAMA 307 2012 1611 1620
    • (2012) JAMA , vol.307 , pp. 1611-1620
    • Sheets, N.C.1    Goldin, G.H.2    Meyer, A.M.3
  • 28


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.